Simplex Trading, LLC Aptinyx Inc. Transaction History

Simplex Trading, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	BUY	$0.12 - $0.69 $12 - $69	100 New	100 $0
Q2 2022 Aug 03, 2022	SELL	$0.38 - $2.58 $40,096 - $272,233	-105,517 Reduced 99.81%	200 $0
Q1 2022 May 02, 2022	BUY	$2.27 - $3.62 $198,454 - $316,478	87,425 Added 477.94%	105,717 $239,000
Q2 2021 Aug 12, 2021	BUY	$2.39 - $3.5 $25,496 - $37,338	10,668 Added 139.93%	18,292 $51,000
Q1 2021 Apr 26, 2021	BUY	$2.86 - $4.33 $21,804 - $33,011	7,624 New	7,624 $22,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.